Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Michaela Karmann |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild alzheimer disease / Arun L.W. Bokde en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 2 (Abril)
[artículo]
Título : Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild alzheimer disease : A functional magnetic resonance imaging study Tipo de documento: texto impreso Autores: Arun L.W. Bokde, Autor ; Michaela Karmann, Autor ; Stefan J. Teipel, Autor Fecha de publicación: 2022 Artículo en la página: pp. 147-156 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Neurodegenerativo, Tratamiento colinérgico, Galantamina, RM farmacológica, Sistema visual, Enfermedad de Alzheimer Resumen: Visual perception has been shown to be altered in Alzheimer disease (AD) patients, and it is associated with decreased cognitive function. Galantamine is an active cholinergic agent, which has been shown to lead to improved cognition in mild to moderate AD patients. Link: ./index.php?lvl=notice_display&id=29518
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 147-156[artículo] Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild alzheimer disease : A functional magnetic resonance imaging study [texto impreso] / Arun L.W. Bokde, Autor ; Michaela Karmann, Autor ; Stefan J. Teipel, Autor . - 2022 . - pp. 147-156.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 147-156
Palabras clave: Neurodegenerativo, Tratamiento colinérgico, Galantamina, RM farmacológica, Sistema visual, Enfermedad de Alzheimer Resumen: Visual perception has been shown to be altered in Alzheimer disease (AD) patients, and it is associated with decreased cognitive function. Galantamine is an active cholinergic agent, which has been shown to lead to improved cognition in mild to moderate AD patients. Link: ./index.php?lvl=notice_display&id=29518